NEW YORK (GenomeWeb) – Reacting to research published last week in which Chinese scientists conducted germline editing on a non-viable human zygote, the National Institutes of Health today firmly came down in opposition to the use of gene editing technologies in the human germline.

"NIH will not fund any use of gene-editing technologies in human embryos," NIH Director Francis Collins wrote in a statement published on the NIH website.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.